Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.
D015110:4-Hydroxycoumarins / Q000627:therapeutic use*; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control*; D010349:Patient Compliance; D010644:Phenprocoumon / Q000627:therapeutic use*; D011897:Random Allocation; D012737:Sex Factors; D013442:Sulfinpyrazone / Q000627:therapeutic use
D015110:4-Hydroxycoumarins; D010644:Phenprocoumon; D001241:Aspirin; D013442:Sulfinpyrazone